Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.
نویسندگان
چکیده
BACKGROUND Fibrinogen is a marker of systemic inflammation and may represent an important biomarker for the progression of chronic obstructive pulmonary disease (COPD). METHODS We used baseline data from the Third National Health and Nutrition Examination Survey (NHANES III) and follow-up mortality data to determine the relation between fibrinogen levels and COPD and to examine how fibrinogen levels at baseline affected long-term outcomes. Elevated fibrinogen was defined as the upper 10% of the fibrinogen level distribution. RESULTS Our study sample included 8,507 subjects, including 245 with Stage 3 or 4 COPD and 826 with Stage 2 COPD. Then, 3,290 of the 8,507 subjects died during the follow-up period. The mean fibrinogen level was 303.6 g/dL and 10% of the sample had levels higher than 403.0 mg/dL. Subjects with Stage 3 or 4 COPD were more likely to have a fibrinogen level > 403.0 mg/dL (odds ratio 3.4, 95% confidence interval [CI], 2.1, 5.6) than were people with normal lung function, after adjusting for covariates. An elevated fibrinogen level increased the risk of mortality (hazards ratio [HR] 1.36, 95% CI 1.13, 1.63) in the entire study sample and in subjects with Stage 3 or 4 (HR 2.11, 95% CI 1.27, 3.50) or Stage 2 (HR 1.45, 95% CI 1.08, 1.96) COPD. CONCLUSION In the nationally representative NHANES III data, impaired lung function is a correlate of fibrinogen levels and the presence of higher fibrinogen levels increases the risk of mortality both in the overall population and among subjects with COPD.
منابع مشابه
ارتباط بین سطح پلاسمائی فیبرینوژن با پیامد در بیماران با تشدید حاد بیماری انسدادی مزمن ریه
Background & Aims: Chronic obstructive pulmonary disease (COPD) is considered as a systemic disease by chronic inflammation with exacerbation episodes. Fibrinogen is a marker of systemic inflammation. The aim of this study was to assess the relation between plasma of fibrinogen level with adverse outcome in COPD patients.Materials & Methods: In this cohort study patients with acute exacerbatio...
متن کاملPrevalence and influence of chronic obstructive pulmonary disease on stroke outcomes in hospitalized stroke patients
BACKGROUND Chronic obstructive pulmonary disease (COPD) and stroke are important causes of death. COPD patients are at higher risk of cerebral hypoxia and aspiration. Yet, relatively little is known about the prevalence of COPD among stroke patients or its impact on outcomes after an index stroke. We assess the prevalence of COPD among hospitalized stroke patients in a nationally representative...
متن کاملFibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
BACKGROUND Fibrinogen is a marker of systemic inflammation and may be important in the pathogenesis and progression of chronic obstructive pulmonary disease (COPD). METHODS We used baseline data from Atherosclerosis Risk in Communities and Cardiovascular Health Studies to determine the relation between fibrinogen levels and COPD and to examine how fibrinogen levels at baseline affected outcom...
متن کاملRisk Perception of Pregnancy Promotes Disapproval ofGestational Surrogacy: Analysis of a Nationally Representative Opinion Survey in Japan
متن کامل
Comparative Analysis of the Public-Use and Restricted-Use LSOA II Linked Mortality File
Introduction The National Center for Health Statistics (NCHS) periodically conducts mortality followup studies through record linkage to administrative data sources for its major populationbased surveys (see NCHS Data Linkage Activities), providing a longitudinal component to nationally representative data. These linked mortality files, in general, fill research gaps by creating data resources ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- COPD
دوره 9 4 شماره
صفحات -
تاریخ انتشار 2012